Case studies

Projects

Eleven projects, each written up as a case study: the question, the approach, the results and their limits. Code for all of them is on GitHub.

Forest plot of GPNMB Mendelian randomisation odds ratios for Parkinson’s disease across SomaScan and Olink instrument sets

MSc dissertation · Statistical genetics

GPNMB and Parkinson’s disease: Mendelian randomisation and colocalisation

Two-sample MR, LD-aware sensitivity analysis and Bayesian colocalisation to test whether genetically predicted GPNMB protein levels are linked to Parkinson’s disease risk. The evidence supports prioritisation, not causality.

  • Mendelian randomisation
  • Colocalisation
  • SuSiE
  • pQTL / eQTL
  • R
  • OpenGWAS
Read case study →
Regional plot of the GPNMB locus from the pipeline: UKB-PPP Olink pQTL association above, Parkinson’s disease GWAS below

Human genetics · Target discovery · Nextflow

Proteome-wide cis-MR and colocalisation scan for Parkinson’s disease

Scaled the dissertation from one protein to a Nextflow pipeline that tests every plasma protein with cis-pQTL MR and colocalisation, FDR control and evidence tiers. Run on 2,940 UKB-PPP Olink and 3,211 SomaScan proteins, it finds known PD risk loci without being told where to look and separates colocalising hits from LD-driven ones.

  • Nextflow
  • Mendelian randomisation
  • Colocalisation
  • UKB-PPP
  • Python
  • pytest
Read case study →
UMAP of 83,484 substantia nigra nuclei coloured by author cell-type annotation

Single-nucleus transcriptomics · Parkinson’s disease

GPNMB in Parkinson’s disease: snRNA-seq re-analysis

Re-analysed 83,484 substantia nigra nuclei from 29 donors to localise GPNMB and test PD–control differences with donor-level pseudobulk models. GPNMB was highest in microglia and about two-fold higher in PD microglia (P = 0.009), a nominal effect that did not survive transcriptome-wide FDR.

  • snRNA-seq
  • Scanpy
  • Pseudobulk
  • PyDESeq2
  • Microglia
  • Propeller
Read case study →
Forest plot of GPNMB hazard ratios: 2.00 unadjusted falling to 1.15 after adjustment for grade and IDH status

Biostatistics · Survival analysis

GPNMB and glioma survival: separating a prognostic signal from confounding

Pre-specified Cox analysis of 624 TCGA diffuse gliomas. GPNMB’s hazard ratio fell from 2.00 per SD unadjusted to 1.15 (95% CI 0.96–1.38) after adjusting for grade and IDH/1p19q status, with an optimism-corrected C-index gain of 0.0009.

  • Cox regression
  • Kaplan–Meier
  • Bootstrap
  • lifelines
  • TCGA
  • pytest
Read case study →
Mean MDS-UPDRS and MoCA trajectories over 15 years in the PPMI Parkinson's disease cohort, observed and model-based

Biostatistics · Longitudinal and survival analysis

Parkinson’s disease progression in PPMI: trajectories and clinical milestones

Mixed-effects and Cox models of 1,789 PPMI participants. Medication-adjusted motor progression slowed from 2.0 to 1.2 MDS-UPDRS III points a year, MoCA held for five years before declining, and age was the strongest predictor of milestones.

  • Mixed-effects models
  • Cox regression
  • Kaplan–Meier
  • statsmodels
  • lifelines
  • PPMI
Read case study →
Galaxy workflow graph for M. tuberculosis WGS variant analysis

Microbial genomics · WGS

M. tuberculosis WGS variant analysis (Galaxy)

End-to-end Galaxy workflow from SRA reads to annotated resistance variants, run on 6 clinical isolates. It called rpoB and katG mutations, confirmed in IGV, and classified 4 isolates as genotypically MDR-TB.

  • WGS
  • Galaxy
  • BWA-MEM2
  • bcftools
  • SnpEff
  • IGV
Read case study →
Dot plot of SNV F1 for DeepVariant and GATK across GIAB region types

Clinical genomics · NGS · Pipelines

Germline variant calling benchmarked against GIAB HG002

Nextflow pipeline from reads to germline SNVs and indels with GATK and DeepVariant, scored against the Genome in a Bottle truth set. On chr20, DeepVariant reaches SNV F1 0.997 and indel F1 0.995; stratified results show where each caller loses accuracy.

  • Nextflow
  • BWA-MEM2
  • GATK
  • DeepVariant
  • hap.py
  • GIAB
Read case study →
Volcano plot of dexamethasone versus control in airway smooth muscle cells with known response genes labelled

Transcriptomics · Pipelines

RNA-seq pipeline (Nextflow + Docker)

Samplesheet-driven Nextflow DSL2 pipeline from raw FASTQ to differential expression in one command, with every tool in a versioned container. Validated on real human data: 8 of 8 known dexamethasone-response genes recovered.

  • Nextflow
  • Docker
  • RNA-seq
  • STAR
  • Salmon
  • DESeq2
Read case study →
Saturation mutagenesis of the TERT promoter with the C228T and C250T cancer mutations highlighted

Regulatory genomics · Machine learning

RegulonML: regulatory variant effects in unseen promoters and enhancers

Predicted the effects of 41,724 single-base variants in 21 regulatory elements from DNA sequence alone, scoring binding-site gain and loss for 1,019 JASPAR motifs and testing only on loci the model had never seen.

  • MPRA
  • Regulatory genomics
  • JASPAR
  • scikit-learn
  • Gradient boosting
  • Grouped CV
Read case study →
Dot plot of answer accuracy and recall at 5 for five retrieval configurations, with accuracy rising as recall rises

Health data engineering · GenAI evaluation

From FHIR to OMOP to RAG: answering clinical questions from notes, and measuring it honestly

Synthetic FHIR records built into a tested OMOP CDM with dbt, notes with exact ground truth, and a retrieval-augmented LLM scored once on 1,200 held-out questions. Accuracy 0.925, with errors traced to retrieval, against a SQL baseline that is exact on structured data.

  • OMOP CDM
  • FHIR
  • dbt
  • pgvector
  • RAG
  • Claude API
Read case study →
Dot plot of mapping agent scores for prompts v1 and v2, with every score higher for v2

Data modelling · Ontologies · AI curation

A Parkinson’s biomarker data model, and an AI mapping agent held to a frozen gold standard

A LinkML model with ontology-bound value sets, 16 validation rules and FAIR provenance; a blind AI agent maps a 68-variable study dictionary, a curator reviews every proposal in SSSOM. Precision 0.906, recall 0.967, 67 of 68 proposals accepted.

  • LinkML
  • SSSOM
  • oaklib
  • MONDO · HPO · LOINC
  • AI curation
Read case study →
Overall and progression-free survival for pembrolizumab and chemotherapy with lognormal extrapolations to 20 years

Health economics · Cost-effectiveness

Pembrolizumab in PD-L1 ≥ 50% NSCLC: a reproducible partitioned survival model

A NICE TA531-style model rebuilt in R from KEYNOTE-024 five-year data: reconstructed patient data checked against published results, DSU-compliant extrapolation, PSA and a price-threshold analysis. At list price the ICER is £52,670 per QALY.

  • Partitioned survival
  • Survival extrapolation
  • PSA
  • NICE HTA
  • R
  • targets
Read case study →

Get in touch

I’m looking for bioinformatics roles in statistical genetics, transcriptomics and NGS analysis, especially where clinical or cell and gene therapy experience helps. Based in London, open to hybrid and remote.